Search
Enanta’s CEO discusses RSV and Covid drug development on its earnings day
- blonca9
- Aug 7, 2023
- 1 min read
Jay Luly goes in depth on antiviral drug development and discusses his company’s efforts to try to develop the first therapeutic for RSV.